SEC Contract Filing

Filing Date: 2022-03-02

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>d323548dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVESTMENT MANAGEMENT TRUST AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Investment Management Trust Agreement (this &#147;Agreement&#148;) is made effective as of February&nbsp;24, 2022 by and between GSR II
Meteora Acquisition Corp., a Delaware corporation (the &#147;Company&#148;) and Continental Stock Transfer&nbsp;&amp; Trust Company, a New York limited purpose trust company (the &#147;Trustee&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company&#146;s registration statement on Form S-1, Registration Statement No.&nbsp;333-261965 (the &#147;Registration
Statement&#148;) and prospectus (the &#147;Prospectus&#148;), for its initial public offering of the Company&#146;s units (the &#147;Units&#148;), each of which consists of one share of the Company&#146;s Class&nbsp;A common stock, par value $0.0001
per share (the &#147;Common Stock&#148;), one redeemable warrant, each warrant entitling the holder thereof to purchase one share of Common Stock and one-sixteenth of one whole right (such initial public offering hereinafter referred to as the
&#147;Offering&#148;), has been declared effective as of the date hereof (the &#147;Effective Date&#148;) by the U.S. Securities and Exchange Commission (capitalized terms used herein and not otherwise defined shall have the meanings set forth in
the Registration Statement); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company has entered into an Underwriting Agreement (the &#147;Underwriting Agreement&#148;)
with Oppenheimer&nbsp;&amp; Co. (&#147;Underwriter&#148;) named therein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, simultaneously with the Offering, the Company&#146;s
sponsor will be purchasing 11,110,000 warrants (&#147;Private Placement Warrants&#148;) from the Company for an aggregate purchase price of $11,110,000 (and additional amounts of Private Placement Warrants from the Company if the Underwriter
exercises its over-allotment option, up to 12,223,750 Private Placement Warrants for an aggregate purchase price of $12,223,750 if the Underwriter&#146;s over-allotment option is exercised in full); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, if a Business Combination (as defined herein) is not consummated within the 15 month period following the closing of the Offering,
upon the request of the Company&#146;s sponsor (the &#147;Sponsor&#148;), the Company may extend such period by three extensions with each extension being one month for up to a maximum of three months in the aggregate, subject to the Sponsor or its
affiliates or permitted designees depositing an amount equal to $0.033 per share of Common Stock then outstanding into the Trust Account (as defined below) for each one month extension (each, an &#147;Extension&#148;) no later than the last day of
such period (the &#147;Applicable Deadline&#148;), in exchange for which the Sponsor will receive additional Private Placement Warrants from the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as described in the Registration Statement, $279,125,000 of the gross proceeds of the Offering and sale of the Private Placement
Warrants ($320,993,750 if the Underwriter&#146;s over-allotment option is exercised in full), along with any funds paid in connection with an Extension, will be delivered to the Trustee to be deposited and held in a segregated trust account located
at all times in the United States (the &#147;Trust Account&#148;) for the benefit of the Company and the holders of shares of the Common Stock included in the Units issued in the Offering as hereinafter provided (the amount to be delivered to the
Trustee (and any interest subsequently earned thereon) is referred to herein as the &#147;Property,&#148; the stockholders for whose benefit the Trustee shall hold the Property will be referred to as the &#147;Public Stockholders,&#148; and the
Public Stockholders and the Company will be referred to together as the &#147;Beneficiaries&#148;); </P>
</DIV></Center>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Underwriting Agreement, a portion of the Property equal to
$9,625,000, or $11,068,750 if the Underwriter&#146;s over-allotment option is exercised in full, is attributable to business combination marketing fee that will be payable by the Company to the Underwriter upon and concurrently with the consummation
of the initial business combination (as described in the Prospectus, a &#147;Business Combination&#148;) (the &#147;Marketing Fee&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company and the Trustee desire to enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee
shall hold the Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size: